Text Size

Magnetically actuated glaucoma drainage device for regulating intraocular pressure after implantation

Pereira ICF, van Mechelen RJS, Wyss HM, Pinchuk L, Beckers HJM, den Toonder JMJ.


  • 2023
  • Microsyst Nanoeng.
View publication
  • Therapeutic Area

    Glaucoma

  • Technology

    Drug Delivery

  • Affiliations

    5600MB Eindhoven, The Netherlands Microsystems, Department of Mechanical Engineering, Eindhoven University of Technology; 5600MB Eindhoven, The Netherlands Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology; 6202AZ Maastricht, The Netherlands University Eye Clinic Maastricht, Maastricht University Medical Centre+ (MUMC+); InnFocus, Inc., a Santen Company, Miami, Florida 33186 USA; Miami, Florida 33136 USA Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Related Publications

Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow Dysfunction

Sharif NA, Ohia SE, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, Njie-Mbye YF


Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.


Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain

Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos M, Espinoza-Cámac N, Oyagüez I, Del Rio T, Rodríguez M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022